Here we show that the TLR7/8 agonist 3M-011 is a potent adjuvant to radiotherapy in syngeneic and orthotopic mouse models of colorectal and pancreatic cancer that resulted in marked local and systemic antitumor activity. The gene discussed is TLR7; the disease is pancreatic neoplasm.